长城医疗保健混合A：2025年第二季度利润5538.21万元 净值增长率17.49%

Core Viewpoint - The AI Fund Changcheng Medical Care Mixed A (000339) reported a profit of 55.38 million yuan for Q2 2025, with a weighted average profit per fund share of 0.4438 yuan, and a net asset value growth rate of 17.49% for the quarter [2]. Fund Performance - As of July 11, the fund's unit net value was 3.217 yuan, with a recent three-month net value growth rate of 23.99%, ranking 31 out of 129 comparable funds [3]. - Over the past six months, the fund achieved a net value growth rate of 49.64%, ranking 28 out of 129 comparable funds [3]. - The one-year net value growth rate was 46.92%, ranking 32 out of 129 comparable funds [3]. - The three-year net value growth rate was -11.10%, ranking 52 out of 105 comparable funds [3]. Risk and Return Metrics - The fund's Sharpe ratio over the past three years was 0.0374, ranking 52 out of 102 comparable funds [9]. - The maximum drawdown over the past three years was 45.19%, with the highest single-quarter drawdown occurring in Q3 2022 at 27.75% [11]. Fund Holdings and Strategy - As of June 30, the fund maintained an average stock position of 84.9% over the past three years, compared to a comparable average of 87.03% [14]. - The fund's top ten holdings as of Q2 2025 included companies such as Rejig Bio, Yipinhong, and BeiGene [18]. - The fund manager indicated a focus on sectors benefiting from policy support and innovative pharmaceuticals, particularly in response to market fluctuations during the quarter [2].